{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T15:22:29Z","timestamp":1786980149382,"version":"build-2736575974"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2025,7,31]],"date-time":"2025-07-31T00:00:00Z","timestamp":1753920000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,7,31]],"date-time":"2025-07-31T00:00:00Z","timestamp":1753920000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Graefes Arch Clin Exp Ophthalmol"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1007\/s00417-025-06928-0","type":"journal-article","created":{"date-parts":[[2025,7,31]],"date-time":"2025-07-31T08:31:48Z","timestamp":1753950708000},"page":"3179-3189","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["3-year real-world outcomes of standalone PreserFlo MicroShunt implantation - effectiveness and safety profile"],"prefix":"10.1007","volume":"263","author":[{"ORCID":"https:\/\/orcid.org\/0009-0007-5471-5860","authenticated-orcid":false,"given":"Adrian","family":"Skowronski","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kirsten Julia","family":"Habbe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kalliopi","family":"Kontopoulou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Markus","family":"Kohlhaas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sofia","family":"Fili","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,31]]},"reference":[{"key":"6928_CR1","doi-asserted-by":"publisher","first-page":"2081","DOI":"10.1016\/j.ophtha.2014.05.013","volume":"121","author":"Y-C Tham","year":"2014","unstructured":"Tham Y-C, Li X, Wong TY et al (2014) Global prevalence of glaucoma and projections of glaucoma burden through 2040: a systematic review and meta-analysis. Ophthalmology 121:2081\u20132090. https:\/\/doi.org\/10.1016\/j.ophtha.2014.05.013","journal-title":"Ophthalmology"},{"key":"6928_CR2","doi-asserted-by":"publisher","unstructured":"(2021) Causes of blindness and vision impairment in 2020 and trends over 30 years, and prevalence of avoidable blindness in relation to VISION 2020: the right to sight: an analysis for the global burden of disease study. Lancet Glob Health 9:e144\u2013e160. https:\/\/doi.org\/10.1016\/S2214-109X(20)30489-7","DOI":"10.1016\/S2214-109X(20)30489-7"},{"key":"6928_CR3","doi-asserted-by":"publisher","first-page":"1901","DOI":"10.1001\/jama.2014.3192","volume":"311","author":"RN Weinreb","year":"2014","unstructured":"Weinreb RN, Aung T, Medeiros FA (2014) The pathophysiology and treatment of glaucoma: a review. JAMA 311:1901\u20131911. https:\/\/doi.org\/10.1001\/jama.2014.3192","journal-title":"JAMA"},{"key":"6928_CR4","doi-asserted-by":"publisher","first-page":"1268","DOI":"10.1001\/archopht.120.10.1268","volume":"120","author":"A Heijl","year":"2002","unstructured":"Heijl A, Leske MC, Bengtsson B et al (2002) Reduction of intraocular pressure and glaucoma progression: results from the early manifest glaucoma trial. Arch Ophthalmol 120:1268\u20131279. https:\/\/doi.org\/10.1001\/archopht.120.10.1268","journal-title":"Arch Ophthalmol"},{"key":"6928_CR5","doi-asserted-by":"publisher","first-page":"180","DOI":"10.5694\/mja2.50020","volume":"210","author":"J Lusthaus","year":"2019","unstructured":"Lusthaus J, Goldberg I (2019) Current management of glaucoma. Med J Aust 210:180\u2013187. https:\/\/doi.org\/10.5694\/mja2.50020","journal-title":"Med J Aust"},{"key":"6928_CR6","doi-asserted-by":"publisher","first-page":"e27834","DOI":"10.7759\/cureus.27834","volume":"14","author":"A Rao","year":"2022","unstructured":"Rao A, Cruz RD (2022) Trabeculectomy: does it have a future?? Cureus 14:e27834. https:\/\/doi.org\/10.7759\/cureus.27834","journal-title":"Cureus"},{"key":"6928_CR7","doi-asserted-by":"publisher","first-page":"650","DOI":"10.1016\/j.ophtha.2018.02.003","volume":"125","author":"SJ Gedde","year":"2018","unstructured":"Gedde SJ, Feuer WJ, Shi W et al (2018) Treatment outcomes in the primary tube versus trabeculectomy study after 1 year of follow-up. Ophthalmology 125:650\u2013663. https:\/\/doi.org\/10.1016\/j.ophtha.2018.02.003","journal-title":"Ophthalmology"},{"key":"6928_CR8","doi-asserted-by":"publisher","first-page":"804","DOI":"10.1016\/j.ajo.2011.10.024","volume":"153","author":"SJ Gedde","year":"2012","unstructured":"Gedde SJ, Herndon LW, Brandt JD et al (2012) Postoperative complications in the tube versus trabeculectomy (TVT) study during five years of follow-up. Am J Ophthalmol 153:804\u2013814e1. https:\/\/doi.org\/10.1016\/j.ajo.2011.10.024","journal-title":"Am J Ophthalmol"},{"key":"6928_CR9","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1097\/ICU.0b013e32834ff1e7","volume":"23","author":"H Saheb","year":"2012","unstructured":"Saheb H, Ahmed IIK (2012) Micro-invasive glaucoma surgery: current perspectives and future directions. Curr Opin Ophthalmol 23:96\u2013104. https:\/\/doi.org\/10.1097\/ICU.0b013e32834ff1e7","journal-title":"Curr Opin Ophthalmol"},{"key":"6928_CR10","doi-asserted-by":"publisher","DOI":"10.2147\/OPTH.S135316","author":"LE Pillunat","year":"2017","unstructured":"Pillunat LE, Erb C, J\u00fcnemann AG et al (2017) Micro-invasive glaucoma surgery (MIGS): a review of surgical procedures using stents. Clin Ophthalmol. https:\/\/doi.org\/10.2147\/OPTH.S135316","journal-title":"Clin Ophthalmol"},{"key":"6928_CR11","doi-asserted-by":"publisher","DOI":"10.3390\/vision6010012","author":"G Gambini","year":"2022","unstructured":"Gambini G, Carl\u00e0 MM, Giannuzzi F et al (2022) Preserflo\u00ae microshunt: an overview of this minimally invasive device for open-angle glaucoma. Vision. https:\/\/doi.org\/10.3390\/vision6010012","journal-title":"Vision"},{"key":"6928_CR12","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1007\/s00347-020-01146-x","volume":"118","author":"EM Hoffmann","year":"2021","unstructured":"Hoffmann EM, Hengerer F, Klabe K et al (2021) Aktuelle glaukomchirurgie (Glaucoma surgery today). Ophthalmologe 118:239\u2013247. https:\/\/doi.org\/10.1007\/s00347-020-01146-x","journal-title":"Ophthalmologe"},{"key":"6928_CR13","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1002\/jbm.b.33525","volume":"105","author":"L Pinchuk","year":"2017","unstructured":"Pinchuk L, Riss I, Batlle JF et al (2017) The development of a micro-shunt made from poly(styrene-block-isobutylene-block-styrene) to treat glaucoma. J Biomed Mater Res B Appl Biomater 105:211\u2013221. https:\/\/doi.org\/10.1002\/jbm.b.33525","journal-title":"J Biomed Mater Res B Appl Biomater"},{"key":"6928_CR14","doi-asserted-by":"crossref","unstructured":"Kerr NM, Ahmed IIK, Pinchuk L et al (2021) PRESERFLO MicroShunt. In: Sng CCA, Barton K (eds) Minimally Invasive Glaucoma Surgery, 1st ed. 2021. Springer Singapore; Imprint Springer, Singapore, pp 91\u2013103","DOI":"10.1007\/978-981-15-5632-6_7"},{"key":"6928_CR15","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1016\/j.ogla.2023.04.002","volume":"6","author":"JJ Armstrong","year":"2023","unstructured":"Armstrong JJ, de Francesco T, Ma J et al (2023) Ab externo SIBS microshunt with mitomycin C for Open-Angle glaucoma: Three-Year results as a primary surgical intervention. Ophthalmol Glaucoma 6:480\u2013492. https:\/\/doi.org\/10.1016\/j.ogla.2023.04.002","journal-title":"Ophthalmol Glaucoma"},{"key":"6928_CR16","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajoint.2024.100054","volume":"1","author":"K Mercieca","year":"2024","unstructured":"Mercieca K, Bhayani R, Martinez-de-la-Casa JM et al (2024) 3-year safety and efficacy results of preserflo\u2122 microshunt in glaucoma patients: a multicentre European cohort study. AJO International 1:100054. https:\/\/doi.org\/10.1016\/j.ajoint.2024.100054","journal-title":"AJO International"},{"key":"6928_CR17","doi-asserted-by":"publisher","first-page":"e58","DOI":"10.1097\/IJG.0000000000000368","volume":"25","author":"JF Batlle","year":"2016","unstructured":"Batlle JF, Fantes F, Riss I et al (2016) Three-Year Follow-up of a novel aqueous humor microshunt. J Glaucoma 25:e58\u201365. https:\/\/doi.org\/10.1097\/IJG.0000000000000368","journal-title":"J Glaucoma"},{"key":"6928_CR18","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/j.ogla.2021.07.008","volume":"5","author":"HJM Beckers","year":"2022","unstructured":"Beckers HJM, Aptel F, Webers CAB et al (2022) Safety and effectiveness of the PRESERFLO\u00ae microshunt in primary Open-Angle glaucoma: results from a 2-Year multicenter study. Ophthalmol Glaucoma 5:195\u2013209. https:\/\/doi.org\/10.1016\/j.ogla.2021.07.008","journal-title":"Ophthalmol Glaucoma"},{"key":"6928_CR19","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1097\/IJG.0000000000001734","volume":"30","author":"JF Batlle","year":"2021","unstructured":"Batlle JF, Corona A, Albuquerque R (2021) Long-term results of the PRESERFLO microshunt in patients with primary open-angle glaucoma from a single-center nonrandomized study. J Glaucoma 30:281\u2013286. https:\/\/doi.org\/10.1097\/IJG.0000000000001734","journal-title":"J Glaucoma"},{"key":"6928_CR20","doi-asserted-by":"publisher","first-page":"e433","DOI":"10.1111\/aos.14602","volume":"99","author":"LMJ Scheres","year":"2021","unstructured":"Scheres LMJ, Kujovic-Aleksov S, Ramdas WD et al (2021) XEN\u00ae gel stent compared to PRESERFLO\u2122 microshunt implantation for primary open-angle glaucoma: two-year results. Acta Ophthalmol 99:e433\u2013e440. https:\/\/doi.org\/10.1111\/aos.14602","journal-title":"Acta Ophthalmol"},{"key":"6928_CR21","doi-asserted-by":"publisher","unstructured":"Storp JJ, Vietmeier FE, Mert\u00e9 R-L et al (2023) Long-Term outcomes of the PRESERFLO microshunt implant in a heterogeneous Glaucoma cohort. J Clin Med 12. https:\/\/doi.org\/10.3390\/jcm12134474","DOI":"10.3390\/jcm12134474"},{"key":"6928_CR22","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1055\/a-2152-8455","volume":"241","author":"M Nobl","year":"2024","unstructured":"Nobl M, Freissinger S, Rudolph K et al (2024) Langzeitdaten von preserflo microshunt versus XEN45 gel stent beim Offenwinkelglaukom (Long-term outcomes of preserflo microshunt versus XEN45 gel stent in Open-Angle Glaucoma). Klin Monbl Augenheilkd 241:805\u2013812. https:\/\/doi.org\/10.1055\/a-2152-8455","journal-title":"Klin Monbl Augenheilkd"},{"key":"6928_CR23","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1016\/j.ophtha.2023.09.023","volume":"131","author":"JF Panarelli","year":"2024","unstructured":"Panarelli JF, Moster MR, Garcia-Feijoo J et al (2024) Ab-Externo microshunt versus trabeculectomy in primary Open-Angle glaucoma: Two-Year results from a randomized, multicenter study. Ophthalmology 131:266\u2013276. https:\/\/doi.org\/10.1016\/j.ophtha.2023.09.023","journal-title":"Ophthalmology"},{"key":"6928_CR24","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-025-92879-9","volume":"15","author":"H Mieno","year":"2025","unstructured":"Mieno H, Mori K, Yoshii K et al (2025) Risk factors and protective strategies for hypotony following Preserflo MicroShunt implantation. Sci Rep 15:8344. https:\/\/doi.org\/10.1038\/s41598-025-92879-9","journal-title":"Sci Rep"},{"key":"6928_CR25","doi-asserted-by":"publisher","first-page":"e779","DOI":"10.1111\/aos.14968","volume":"100","author":"KR Pillunat","year":"2022","unstructured":"Pillunat KR, Herber R, Haase MA et al (2022) PRESERFLO\u2122 microshunt versus trabeculectomy: first results on efficacy and safety. Acta Ophthalmol 100:e779\u2013e790. https:\/\/doi.org\/10.1111\/aos.14968","journal-title":"Acta Ophthalmol"},{"key":"6928_CR26","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-025-87259-2","volume":"15","author":"Y Miura","year":"2025","unstructured":"Miura Y, Fukuda K, Yamashiro K (2025) Comparison of outcomes with and without intrastent placement during PMS surgery. Sci Rep 15:2981. https:\/\/doi.org\/10.1038\/s41598-025-87259-2","journal-title":"Sci Rep"},{"key":"6928_CR27","doi-asserted-by":"publisher","unstructured":"Chami J, Tan JCK, Manning D et al. (2025) Comparative Study of Early Safety and Effectiveness Outcomes of the PreserFlo MicroShunt with and without an Intraluminal Suture Stent. Ophthalmol Glaucoma. https:\/\/doi.org\/10.1016\/j.ogla.2025.03.003","DOI":"10.1016\/j.ogla.2025.03.003"},{"key":"6928_CR28","doi-asserted-by":"publisher","first-page":"3925","DOI":"10.1007\/s00417-024-06567-x","volume":"262","author":"R Verma-Fuehring","year":"2024","unstructured":"Verma-Fuehring R, Dakroub M, Bamousa A et al (2024) The use of intraluminal PRESERFLO stenting in avoiding early postoperative hypotony. Graefes Arch Clin Exp Ophthalmol 262:3925\u20133932. https:\/\/doi.org\/10.1007\/s00417-024-06567-x","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"6928_CR29","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1016\/j.ogla.2021.08.005","volume":"5","author":"AM Fea","year":"2022","unstructured":"Fea AM, Laffi GL, Martini E et al (2022) Effectiveness of microshunt in patients with primary Open-Angle and pseudoexfoliative glaucoma: A retrospective European multicenter study. Ophthalmol Glaucoma 5:210\u2013218. https:\/\/doi.org\/10.1016\/j.ogla.2021.08.005","journal-title":"Ophthalmol Glaucoma"},{"key":"6928_CR30","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines13020364","author":"S Dierse","year":"2025","unstructured":"Dierse S, Esser EL, Mert\u00e9 R-L et al (2025) Preserflo-MicroShunt: postoperative effects on endothelial cell density and corneal thickness. Biomedicines. https:\/\/doi.org\/10.3390\/biomedicines13020364","journal-title":"Biomedicines"},{"key":"6928_CR31","doi-asserted-by":"publisher","first-page":"3661","DOI":"10.1007\/s00417-024-06508-8","volume":"262","author":"CJ Gassel","year":"2024","unstructured":"Gassel CJ, Wenzel DA, Nasyrov E et al (2024) Intermediate-term impact on corneal endothelial cells and efficacy of preserflo microshunt implantation in patients with open-angle glaucoma - a prospective study over two years. Graefes Arch Clin Exp Ophthalmol 262:3661\u20133670. https:\/\/doi.org\/10.1007\/s00417-024-06508-8","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"6928_CR32","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1055\/a-2495-8580","volume":"242","author":"E Grobsh\u00e4user","year":"2025","unstructured":"Grobsh\u00e4user E, Cunha Vaz Martinho A, Gatzioufas Z et al (2025) Untersuchung der endothelzellendichte Nach preserflo-Implantation Im vergleich zu augen Ohne preserflo-Implantation\u2013 eine retrospektive analyse (Investigation of endothelial cell density after preserflo implantation compared to contralateral eyes without preserflo implantation - A retrospective Analysis). Klin Monbl Augenheilkd 242:392\u2013397. https:\/\/doi.org\/10.1055\/a-2495-8580","journal-title":"Klin Monbl Augenheilkd"},{"key":"6928_CR33","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1007\/s40123-021-00428-0","volume":"11","author":"M Ibarz-Barber\u00e1","year":"2022","unstructured":"Ibarz-Barber\u00e1 M, Morales-Fern\u00e1ndez L, Corroto-Cuadrado A et al (2022) Corneal endothelial cell loss after PRESERFLO\u2122 microshunt implantation in the anterior chamber: anterior segment OCT tube location as a risk factor. Ophthalmol Ther 11:293\u2013310. https:\/\/doi.org\/10.1007\/s40123-021-00428-0","journal-title":"Ophthalmol Ther"},{"key":"6928_CR34","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/j.ajo.2023.11.011","volume":"259","author":"A Rabiolo","year":"2024","unstructured":"Rabiolo A, Toscani R, Sacchi M et al (2024) Risk factors for failure in glaucoma patients undergoing microshunt implantation. Am J Ophthalmol 259:117\u2013130. https:\/\/doi.org\/10.1016\/j.ajo.2023.11.011","journal-title":"Am J Ophthalmol"},{"key":"6928_CR35","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/j.ajo.2020.02.020","volume":"215","author":"MB Schlenker","year":"2020","unstructured":"Schlenker MB, Durr GM, Michaelov E et al (2020) Intermediate outcomes of a novel standalone ab externo SIBS microshunt with mitomycin C. Am J Ophthalmol 215:141\u2013153. https:\/\/doi.org\/10.1016\/j.ajo.2020.02.020","journal-title":"Am J Ophthalmol"}],"container-title":["Graefe's Archive for Clinical and Experimental Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00417-025-06928-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00417-025-06928-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00417-025-06928-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,4]],"date-time":"2025-12-04T03:51:03Z","timestamp":1764820263000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00417-025-06928-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,31]]},"references-count":35,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2025,11]]}},"alternative-id":["6928"],"URL":"https:\/\/doi.org\/10.1007\/s00417-025-06928-0","relation":{},"ISSN":["0721-832X","1435-702X"],"issn-type":[{"value":"0721-832X","type":"print"},{"value":"1435-702X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,31]]},"assertion":[{"value":"15 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 July 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 July 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 July 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Informed consent was obtained from all patients before surgery. The study and proposed procedure were approved by the institutional review board committee of St. Johannes Hospital in Dortmund and was in compliance with the tenets of the Declaration of Helsinki.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"All authors certify that they have no affiliations with or involvement in any organization or entity with any financial interest or non-financial interest in the subject matter or materials discussed in this manuscript.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest\/competing interests"}}]}}